Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

640 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment.
Takashima T, Enomoto H, Ninomiya T, Kim SR, Okushin H, Sugano M, Imoto S, Yano Y, Ooka T, Seo Y, Kasugai H, Muramatsu A, Jomura H, Shimomura S, Shindo M, Nakamura H, Aizawa N, Iwata Y, Saito M, Imanishi H, Iijma H, Nishiguchi S. Takashima T, et al. Among authors: sugano m. Hepatol Res. 2014 Jun;44(6):597-607. doi: 10.1111/hepr.12153. Epub 2013 May 31. Hepatol Res. 2014. PMID: 23639109
Mutational diversity of NS5A and NS3 during triple therapy (telaprevir, pegylated-interferon-α 2b and ribavirin) for genotype 1b chronic hepatitis C: The Kobe Hepatitis Therapeutic Group.
Bai F, Yano Y, Kim SR, Seo Y, Miki A, Saito M, Hirano H, Momose K, Minami A, Hatazawa Y, Hayakumo T, Widasari DI, Rinonce HT, Sugano M, Tani S, Yoon S, Imoto S, Azuma T, Hotta H, Hayashi Y. Bai F, et al. Among authors: sugano m. Int J Mol Med. 2014 Jun;33(6):1652-6. doi: 10.3892/ijmm.2014.1706. Epub 2014 Mar 19. Int J Mol Med. 2014. PMID: 24647743
Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system.
Ninomiya T, Yoon S, Hayashi Y, Sugano M, Kumon Y, Seo Y, Shimizu K, Kasuga M. Ninomiya T, et al. Among authors: sugano m. J Gastroenterol Hepatol. 1998 Jan;13(1):68-74. doi: 10.1111/j.1440-1746.1998.tb00548.x. J Gastroenterol Hepatol. 1998. PMID: 9737575
Factors associated with the decrease in hepatitis B surface antigen titers following interferon therapy in patients with chronic hepatitis B: Is interferon and adefovir combination therapy effective?
Yano Y, Seo Y, Hayashi H, Hatazawa Y, Hirano H, Minami A, Kawano Y, Saito M, Ninomiya T, Sugano M, Yamada H, Kitajima N, Yoon S, Hayashi Y. Yano Y, et al. Among authors: sugano m. Biomed Rep. 2017 Sep;7(3):257-262. doi: 10.3892/br.2017.944. Epub 2017 Jul 18. Biomed Rep. 2017. PMID: 28819561 Free PMC article.
Hypervascular liver nodules in heavy drinkers of alcohol.
Kim SR, Maekawa Y, Imoto S, Sugano M, Kudo M. Kim SR, et al. Among authors: sugano m. Alcohol Clin Exp Res. 2004 Aug;28(8 Suppl Proceedings):174S-180S. doi: 10.1097/01.alc.0000133545.36628.77. Alcohol Clin Exp Res. 2004. PMID: 15318108
Double-Filtration Plasmapheresis plus Interferon-β for HCV-1b Patients with Non-Sustained Virological Response to Previous Combination Therapy.
Kim SR, Saito J, Imoto S, Komaki T, Nagata Y, Kim KI, Sasase N, Kimura N, Sasatani K, Konishi E, Hasegawa Y, Fujinami A, Ohta M, El-Shamy A, Tanaka Y, Sugano M, Sakashita M, Nakamura A, Tsuchida S, Makino T, Kawada T, Nakajima T, Morikawa T, Muramatsu A, Kasugai H, Hotta H, Kudo M. Kim SR, et al. Among authors: sugano m. Digestion. 2011;84 Suppl 1:10-6. doi: 10.1159/000333209. Epub 2011 Dec 2. Digestion. 2011. PMID: 22156480
640 results